Comment on "Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease"

被引：1
|
作者：
Chen, Yu-Syuan [1 ]
Hung, Yao-Min [2 ]
Wei, James Cheng-Chung [3 ,4 ,5 ]
机构：
[1] Chung Shan Med Univ, Med, Taichung, Taiwan
[2] Kaohsiung Municipal United Hosp, Dept Internal Med, Kaohsiung, Taiwan
[3] Chung Shan Med Univ Hosp, Dept Allergy Immunol & Rheumatol, Taichung, Taiwan
[4] Chung Shan Med Univ, Inst Med, Coll Med, Taichung, Taiwan
[5] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷 / 01期
关键词：
D O I：
10.1016/j.jhep.2021.12.032
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：259 / 260
页数：2
相关论文
共 50 条
  • [41] Associations of an overall healthy lifestyle with the risk of metabolic dysfunction-associated fatty liver disease
    Yuan, Caimei
    Zhang, Chengjing
    Geng, Xin
    Feng, Chengwu
    Su, Yang
    Wu, Yinfan
    Wang, Ying
    Chen, Li
    Ding, Qiurong
    Voortman, Trudy
    Wang, Hongyang
    Zong, Geng
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [42] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
    Han, A. Lum
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [43] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
    A Lum Han
    Diabetology & Metabolic Syndrome, 14
  • [44] FERRITIN IS ASSOCIATED WITH INCREASED MORTALITY, PROGRESSION TO CIRRHOSIS, AND DEVELOPMENT OF CARDIOVASCULAR DISEASE IN METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE
    Suresh, Deepika
    Miller, Matthew
    Wijarnpreecha, Karn
    Chen, Vincent
    HEPATOLOGY, 2022, 76 : S714 - S715
  • [45] Metabolic Dysfunction-Associated Fatty Liver Disease Increases the Risk of Gastroesophageal Reflux Symptoms
    He, Yuan
    Duan, Zhi-Jun
    Wang, Cheng-Fang
    Wei, Yu-Shan
    Cai, Ming-Xu
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 199 - 207
  • [46] Risk Factors for Advanced Fibrosis in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease
    Sachar, Moniyka
    Pan, Jason
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S561 - S561
  • [47] Remnant cholesterol, a potential risk factor of metabolic dysfunction-associated fatty liver disease
    Hao, Xuanyu
    Li, Dongyang
    Huang, Xingyong
    Wang, Tingting
    Wu, Peng
    Shen, Lufan
    Zhang, Kai
    Sun, Siyu
    NUTRITION & METABOLISM, 2025, 22 (01)
  • [48] Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated with Increased Risk of Kidney Cancer: A Nationwide Study
    Oh, Juyeon
    Kim, Beom Kyung
    Yoon, Jin-Ha
    Lee, Hyung Ho
    Park, Heejoo
    Lee, Jian
    Park, Youngsun
    Yun, Byungyoon
    Chung, Jinsoo
    CANCERS, 2024, 16 (18)
  • [49] Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States
    Kim, Donghee
    Konyn, Peter
    Sandhu, Keeryth K.
    Dennis, Brittany B.
    Cheung, Amanda C.
    Ahmed, Aijaz
    JOURNAL OF HEPATOLOGY, 2021, 75 (06) : 1284 - 1291
  • [50] Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depression
    Astrom, Hanne
    Shang, Ying
    Hagstrom, Hannes
    Wester, Axel
    LIVER INTERNATIONAL, 2024, 44 (10) : 2551 - 2563
12345